Soborg, Denmark

Marit Kristiansen

USPTO Granted Patents = 22 

 

Average Co-Inventor Count = 4.3

ph-index = 9

Forward Citations = 427(Granted Patents)


Location History:

  • S.o slashed.borg, DK (1999 - 2000)
  • Søborg, DK (2003 - 2012)
  • Soborg, DK (1992 - 2013)
  • Soeborg, DK (1998 - 2014)

Company Filing History:


Years Active: 1992-2014

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Unveiling the Inventive Journey of Marit Kristiansen from Soborg, DK

Introduction:

Marit Kristiansen, a prolific inventor hailing from Soborg, DK, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 22 patents. His groundbreaking work revolves around the development of novel compounds aimed at enhancing glucokinase activity for the treatment of various diseases, particularly type 2 diabetes.

Latest Patents:

Marit Kristiansen's recent patents showcase his expertise in the creation of innovative pharmaceutical solutions. One such patent involves Heteroaryl-ureas designed as glucokinase activators (formula I), which play a crucial role in managing diseases where boosting glucokinase activity is advantageous. Additionally, the invention of Urea glucokinase activators highlights his commitment to advancing treatments for type 2 diabetes and other related conditions.

Career Highlights:

Having worked with renowned companies such as Novo Nordisk A/S, Marit Kristiansen has honed his skills and expertise in the pharmaceutical industry. His tenure at Novo Nordisk A/S has been instrumental in translating his innovative ideas into tangible patents that have the potential to revolutionize the treatment landscape for various medical conditions.

Collaborations:

Throughout his career, Marit Kristiansen has collaborated with esteemed professionals in the field, including Jane Marie Lundbeck and Lone Jeppesen. These collaborations have not only enriched his inventive process but have also fostered a culture of innovation and excellence within the industry.

Conclusion:

In conclusion, Marit Kristiansen stands as a trailblazing inventor whose dedication to advancing pharmaceutical solutions has led to the development of groundbreaking patents in the realm of glucokinase activators. His contributions underscore the importance of innovation in addressing complex medical challenges, paving the way for enhanced treatment options and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…